Prodrugs of CGRP receptor antagonist

Details for Australian Patent Application No. 2009212514 (hide)

Owner Merck & Co., Inc.

Inventors Bell, Ian M.; Stella, Valentino J.; Gallicchio, Steven N.

Agent Spruson & Ferguson

Pub. Number AU-A-2009212514

PCT Pub. Number WO2009/100090

Priority 61/063,656 05.02.08 US

Filing date 4 February 2009

Wipo publication date 13 August 2009

International Classifications

A61K 31/44 (2006.01) - Non-condensed pyridines

A61K 31/517 (2006.01) - ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine

A61K 31/55 (2006.01) - having seven-membered rings, e.g. azelastine, pentylenetetrazole

Event Publications

15 July 2010 PCT application entered the National Phase

  PCT publication WO2009/100090 Priority application(s): WO2009/100090

20 January 2011 Alteration of Name

  The name of the applicant has been altered to Merck Sharp & Dohme Corp.

4 October 2012 Alteration of Name

  The name of the applicant has been altered to Merck Sharp & Dohme Corp.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009212519-3-(4-fluorophenyl)-3-hydroxy-2-amino-p ropionic acid amides and related compounds having analgesic activity

2009212499-Automatic battery reconnection